CTX114
Asset
Inhibits complement attack at the retinal surface to protect retinal and photoreceptor cells.
- Stage
- Phase 1
- Modality
- Not known
- Target
- Not known
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Geographic atrophy
Phase 1, characterbio.com, Oct 30, 2026
In the full profile
- Owner and partners1
Every asset’s record: target, stage, trials and the evidence behind it.